Next Article in Journal
Preclinical Drug Response Metric Based on Cellular Response Phenotype Provides Better Pharmacogenomic Variables with Phenotype Relevance
Next Article in Special Issue
Activation of Host-NLRP3 Inflammasome in Myeloid Cells Dictates Response to Anti-PD-1 Therapy in Metastatic Breast Cancers
Previous Article in Journal
Quality Assessment of Investigational Medicinal Products in COVID-19 Clinical Trials: One Year of Activity at the Clinical Trials Office
Previous Article in Special Issue
Implications of Antigen Selection on T Cell-Based Immunotherapy
 
 
Article

Article Versions Notes

Pharmaceuticals 2021, 14(12), 1322; https://0-doi-org.brum.beds.ac.uk/10.3390/ph14121322
Action Date Notes Link
article xml file uploaded 17 December 2021 14:04 CET Original file -
article xml uploaded. 17 December 2021 14:04 CET Update -
article pdf uploaded. 17 December 2021 14:04 CET Version of Record https://0-www-mdpi-com.brum.beds.ac.uk/1424-8247/14/12/1322/pdf-vor
article supplementary file uploaded. 17 December 2021 14:04 CET - https://0-www-mdpi-com.brum.beds.ac.uk/1424-8247/14/12/1322#supplementary
article html file updated 17 December 2021 14:06 CET Original file -
article xml file uploaded 21 December 2021 11:00 CET Update -
article xml uploaded. 21 December 2021 11:00 CET Update https://0-www-mdpi-com.brum.beds.ac.uk/1424-8247/14/12/1322/xml
article pdf uploaded. 21 December 2021 11:00 CET Updated version of record https://0-www-mdpi-com.brum.beds.ac.uk/1424-8247/14/12/1322/pdf
article html file updated 21 December 2021 11:02 CET Update -
article html file updated 30 July 2022 22:58 CEST Update https://0-www-mdpi-com.brum.beds.ac.uk/1424-8247/14/12/1322/html
Back to TopTop